April - June 2007: 
Volume 20, Issue 2

Click on the image to download the Issue in PDF format.


Long acting β2-agonists in asthma: friend or foe?
Asthma is a common disease that is encountered all across the spectrum from primary to tertiary care. In most cases the diagnosis of asthma is made easily, based on the response to standard doses of inhaled therapy.